SBTX

SkinBioTherapeutics
SBTX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
£36.88M
EV
£36.67M
Shares Outstanding
272.98M
Beta
0.70

Wall Street View

Analyst Rating
BUY
Analyst Target Price
£0.29
P/E 2025E
-
P/Revenue 2025E
8.02x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About SkinBioTherapeutics plc

gainify
SBTX

SkinBioTherapeutics plc

SBTX

SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin he...

Sector

Healthcare

Industry

Biotechnology

CEO

Ashman, Stuart

Employees

15

IPO Date

2017-04-05

Headquarters

The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, Tyne and Wear, NE4 5TF, United Kingdom

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.